Intranasal administration of interleukin-4 ameliorates depression-like behavior and biochemical alterations in mouse submitted to the chronic unpredictable mild stress: modulation of neuroinflammation and oxidative stress.
CUMS
HPA axis
Interleukin-4
Neuroinflammation
Neuromodulation
Oxidative stress
Journal
Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
30
03
2022
accepted:
03
02
2023
pubmed:
2
3
2023
medline:
15
3
2023
entrez:
1
3
2023
Statut:
ppublish
Résumé
Physical and psychological stress modulates the hypothalamic pituitary adrenal (HPA) axis, and the redox and inflammatory systems. Impairments in these systems have been extensively reported in major depression (MD) patients. Therefore, our study aimed to investigate the effects of the intranasal administration of interleukin-4 (IL-4) in mice with depressive-like behavior induced by chronic unpredictable mild stress (CUMS) for 28 days. On the 28th day, mice received IL-4 intranasally (1 ng/mouse) or vehicle (sterile saline), and after 30 min, they were submitted to behavioral tests or euthanasia for blood collection and removal of the adrenal glands, axillary lymph nodes, spleen, thymus, prefrontal cortices (PFC), and hippocampi (HC). A single administration of IL-4 reversed CUMS-induced depression-like behavior in the tail suspension test and splash test, without evoking locomotor changes. IL-4 administration reduced the plasma levels of corticosterone and the increased weight of suprarenal glands in stressed mice. Moreover, IL-4 restored the expression of nuclear factor erythroid 2-related factor 2 (NRF2), nuclear factor kappa B (NF-kB), interleukin 1 beta (IL-1β), IL-4, brain derived neurotrophic factor (BDNF), and indoleamine 2,3-dioxygenase (IDO) in the PFC and HC and modulated oxidative stress markers in these brain structures in stressed mice. Our results showed for the first time the antidepressant-like effect of IL-4 through the modulation of neuroinflammation and oxidative stress. The potential effect of IL-4 administered intranasally arises as an innovative strategy for MD treatment.
Identifiants
pubmed: 36856802
doi: 10.1007/s00213-023-06336-4
pii: 10.1007/s00213-023-06336-4
doi:
Substances chimiques
Interleukin-4
207137-56-2
Brain-Derived Neurotrophic Factor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
935-950Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Abumaria N, Rygula R, Hiemke C, Fuchs E, Havemann-Reinecke U, Rüther E, Flügge G, Arango V, Underwood MD, Gubbi AV et al (2014) Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. Eur J Pharmacol 4:1702–1714
Aebi H (1984) Oxygen radicals in biological systems. Methods Enzymol 105:121–126
pubmed: 6727660
doi: 10.1016/S0076-6879(84)05016-3
Bahr R, Lopez A, Rey JA (2019) Intranasal esketamine (SpravatoTM) for use in treatment-resistant depression in conjunction with an oral antidepressant. P T 44:340–375
pubmed: 31160868
pmcid: 6534172
Brites D, Fernandes A (2015) Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation. Front Cell Neurosci 9:1–20
doi: 10.3389/fncel.2015.00476
Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, Martino G, Schwartz M (2006) Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 31:149–160
pubmed: 16297637
doi: 10.1016/j.mcn.2005.10.006
Butti E, Bergami A, Recchia A, Brambilla E, Del Carro U, Amadio S, Cattalini A, Esposito M, Stornaiuolo A, Comi G et al (2008) IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther 15:504–515
pubmed: 18239607
doi: 10.1038/gt.2008.10
Camargo RG, dos Reis Riccardi DM, Ribeiro HQT, Carnevali LC, de Matos-Neto EM, Enjiu L, Neves RX, Lima JDCC, GalvãoFiguerêdo R, de Alcântara PSM et al (2015) Nf-κbp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients. Nutrients 7:4465–4479
pubmed: 26053616
doi: 10.3390/nu7064465
Cavaillon J (2001) Pro-versus anti-inflammatory cytokines: myth or reality. Cell Mol Bio 47:695–702
Choi P, Reiser H (1998) IL-4: role in disease and regulation of production. Clin Exp Immunol 113:317–319
pubmed: 9737656
pmcid: 1905061
doi: 10.1046/j.1365-2249.1998.00690.x
Choi SH, Bylykbashi E, Chatila ZK, Lee SW, Pulli B, Clemenson GD, Kim E, Rompala A, Oram MK, Asselin C et al (2018) Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model. Science 361:6406
doi: 10.1126/science.aan8821
Cobley JN, Fiorello ML, Bailey DM (2018) 13 reasons why the brain is susceptible to oxidative stress. Redox Biol 15:490–503
pubmed: 29413961
pmcid: 5881419
doi: 10.1016/j.redox.2018.01.008
Dantzer R (2009) Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am 29:247–264
pubmed: 19389580
pmcid: 2740752
doi: 10.1016/j.iac.2009.02.002
DeLano WL (2002) The PyMol Molecular Graphics System. Prot 30:442–454
Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, Kipnis J (2010) Regulation of learning and memory by meningeal immunity: A key role for IL-4. J Exp Med 207:1067–1080
pubmed: 20439540
pmcid: 2867291
doi: 10.1084/jem.20091419
Ducottet C, Aubert A, Belzung C (2004) Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mouse. Behav Brain Res 155:291–299
pubmed: 15364489
doi: 10.1016/j.bbr.2004.04.020
Felger JC (2019) Role of inflammation in depression and treatment implications. Handbook of Experimental Pharmacology. Springer, New York LLC, pp 255–286
Francos-Quijorna I, Amo-Aparicio J, Martinez-Muriana A, López-Vales R (2016) IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injury. Glia 64:2079–2092
pubmed: 27470986
doi: 10.1002/glia.23041
Gadani SP, Cronk JC, Norris GT, Kipnis J (2012) IL-4 in the brain: a cytokine to remember. J Immunol 189:4213–4219
pubmed: 23087426
doi: 10.4049/jimmunol.1202246
Gray JJ, Moughon S, Wang C, Schueler-Furman O, Kuhlman B, Rohl CA, Baker D (2003) Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. J Mol Biol 331:281–299
pubmed: 12875852
doi: 10.1016/S0022-2836(03)00670-3
Guest FL, Martins-de-Souza D, Rahmoune H, Bahn S, Guest PC (2013) Os efeitos do estresse na função do eixo hipotalâmico-pituitário-adrenal em indivíduos com esquizofrenia. Rev Psiquiatr Clin 40:20–27
doi: 10.1590/S0101-60832012005000002
Hahn GF, de Oliveira JR, Bock PM (2017) O papel do fator nuclear eritróide 2 relacionado ao fator 2 (Nrf2) no diabetes mellitus. Clin Biol Res 37(3):203–213
Han A, Yeo H, Park MJ, Kim SH, Choi HJ, Hong CW, Kwon MS (2015) IL-4/10 prevents stress vulnerability following imipramine discontinuation. J Neuroinflammation 12:197
pubmed: 26521132
pmcid: 4628271
doi: 10.1186/s12974-015-0416-3
Hanson LR, Fine JM, Svitak AL, Faltesek KA (2013) Intranasal administration of CNS therapeutics to awake mice. J Vis Exp. 1–7.
Hashimoto K (2018) Essential role of keap1-Nrf2 signaling in mood disorders: overview and future perspective. Front Pharmacol 9:1182
pubmed: 30386243
pmcid: 6198170
doi: 10.3389/fphar.2018.01182
Hernández-Santoyo A, Tenorio-Barajas AY, Victor-Altuzar V, Vivanco-Cid H, Mendoza-Barrera C (2013) Protein-protein and protein-ligand docking. Protein Eng Technol Appl. 3:63–81
Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501
pubmed: 11027914
doi: 10.1016/S0893-133X(00)00159-7
Keller LA, Merkel O, Popp A (2021) Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Del Trans Res 12:735–757
doi: 10.1007/s13346-020-00891-5
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the arrive guidelines for reporting animal research. PLoS Biol 8:6–11
doi: 10.1371/journal.pbio.1000412
Kryst J, Kawalec P, Pilc A (2020) Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder. Expert Opin Pharmacother 21:9–20
pubmed: 31663783
doi: 10.1080/14656566.2019.1683161
Laskowski RA, Hutchinson GE, Michie AD, Wallace AC, Jones ML, Thornton JM (1997) PDBsum: a web-based database of summaries and analyses of all PDB structures. Trends Biochem Sci 22(12):488–490
pubmed: 9433130
doi: 10.1016/S0968-0004(97)01140-7
LeffGelman P, Mancilla-Herrera I, Flores-Ramos M, Saravia Takashima MF, Cruz Coronel FM, Cruz Fuentes C, Pérez Molina A, Hernández-Ruiz J, Silva-Aguilera FS, Farfan-Labonne B et al (2019) The cytokine profile of women with severe anxiety and depression during pregnancy. BMC Psychiatry 19:1–11
Liebert MA (2005) By Oxidative Stress. Stress Int J Biol Stress 7:1664–1673
Loetchutinat C, Kothan S, Dechsupa S, Meesungnoen J, Jay-Gerin JP, Mankhetkorn S (2005) Spectrofluorometric determination of intracellular levels of reactive oxygen species in drug-sensitive and drug-resistant cancer cells using the 2′,7′-dichlorofluorescein diacetate assay. Radiat Phys Chem 72:323–331
doi: 10.1016/j.radphyschem.2004.06.011
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
pubmed: 14907713
doi: 10.1016/S0021-9258(19)52451-6
Maddock C, Pariante CM (2001) How does stress affect you? An overview of stress, immunity, depression and disease. Epidemiol Psichiatr Soc 10:153–162
pubmed: 11787449
doi: 10.1017/S1121189X00005285
Misra HP, Fridovich I (1972) The role of superoxide anion in the epinephrine and a simple assay for superoxide dismutase * autoxidation of. J Biol Chem 247:3170–3175
pubmed: 4623845
doi: 10.1016/S0021-9258(19)45228-9
Morikawa O, Sakai N, Obara H, Saito N (1998) Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol 349:317–324
pubmed: 9671113
doi: 10.1016/S0014-2999(98)00187-3
Mössner R, Heils A, Stöber G, Okladnova O, Daniel S, Lesch KP (1998) Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int 33:251–254
pubmed: 9759920
doi: 10.1016/S0197-0186(98)00026-6
Mössner R, Daniel S, Schmitt A, Albert D, Lesch KP (2001) Modulation of serotonin transporter function by interleukin-4. Life Sci 68:873–880
pubmed: 11213357
doi: 10.1016/S0024-3205(00)00992-9
Murphy ME, Noack E (1994) Nitric oxide assay using hemoglobin method. Methods Enzymol 233:240–250
pubmed: 8015461
doi: 10.1016/S0076-6879(94)33027-1
O’Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mouse. Mol Psychiatry 14:511–522
pubmed: 18195714
doi: 10.1038/sj.mp.4002148
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
pubmed: 36810
doi: 10.1016/0003-2697(79)90738-3
Pariante CM (2006) The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol 20:79–84
pubmed: 16785275
doi: 10.1177/1359786806066063
Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464–468
pubmed: 18675469
doi: 10.1016/j.tins.2008.06.006
Pariante CM, Pearce BD, Pisell TL et al (1999) The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140:4359–4366
pubmed: 10465310
doi: 10.1210/endo.140.9.6986
Rosmond R, Bjorntorp P (2000) The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 247:188–197
pubmed: 10692081
doi: 10.1046/j.1365-2796.2000.00603.x
Rossetti AC, Paladini MS, Trepci A, Mallien A, Riva MA, Gass P, Molteni R (2019) Differential neuroinflammatory response in male and female mouse: a role for BDNF. Front Mol Neurosci 12:1–14
doi: 10.3389/fnmol.2019.00166
Sangomla S, Saifi MA, Khurana A, Godugu C (2018) Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation. J Trace Elem Med Biol 47:53–62
pubmed: 29544808
doi: 10.1016/j.jtemb.2018.01.016
Sarjan HN, Yajurvedi HN (2019) Duration dependent effect of chronic stress on primary and secondary lymphoid organs and their reversibility in rats. Immunobiology 224:133–141
doi: 10.1016/j.imbio.2018.09.007
Shah M, Zaneb H, Masood S, Khan I, Sikandar A, Ashraf S, Rehman HF, Usman MM, Khan FA, Amanullah H et al (2018) Effect of zinc and probiotics supplementation on performance and immune organs morphology in heat stressed broilers. South African J Anim Sci 48:1017–1025
Song Y, Sun R, Ji Z, Li X, Fu Q, Ma S (2018) Perilla aldehyde attenuates CUMS-induced depressive-like behaviors via regulating TXNIP/TRX/NLRP3 pathway in rats. Life Sci 206:117–124
pubmed: 29800538
doi: 10.1016/j.lfs.2018.05.038
Sowa-Kućma M, Styczeń K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G, Maes M (2018) Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia. Neurotox Res 33:448–460
pubmed: 29103192
doi: 10.1007/s12640-017-9835-5
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mouse. Psychopharmacology 85:367–370
pubmed: 3923523
doi: 10.1007/BF00428203
Tsai MC, Huang TL (2015) Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder. Psychiatry Res 235:38–42
pubmed: 26677733
doi: 10.1016/j.psychres.2015.12.005
Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269–1274
pubmed: 14502282
doi: 10.1038/nm934
Vogelaar CF, Shibajee Mandal SL, Birkner K, Birkenstock J, Bühler U, Schnatz A, Raine CS, Bittner S, Vogt J, Kipnis J, Nitsch R et al (2018) Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation. Sci Transl Med 10:1–13
doi: 10.1126/scitranslmed.aao2304
Wachholz S, Knorr A, Mengert L, Plümper J, Sommer R, Juckel G, Friebe A (2017) Interleukin-4 is a participant in the regulation of depressive-like behavior. Behav Brain Res 326:165–172
pubmed: 28315756
doi: 10.1016/j.bbr.2017.03.020
Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83:482–504
pubmed: 17582919
doi: 10.1037/0033-2909.83.3.482
World Health Organization (2017) Depression and other common mental disorders: global health estimates. World Health Organization 1–24. https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf . Accessed 22 Dec 2022
Zenker N, Bernstein D (1958) The estimation of small amounts of corticosterone in rat plasma. J Biol Chem 231:695–701
pubmed: 13539004
doi: 10.1016/S0021-9258(18)70434-1
Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J (2015) Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci 35:11281–11291
pubmed: 26269636
pmcid: 4532758
doi: 10.1523/JNEUROSCI.1685-15.2015